Abstract
Background: ADHD is one of the most common neurodevelopmental and psychiatric disorders of childhood. NFB is a comprehensive training system that facilitates changes in brain waves. The aim of this study is to assess whether NFB can be considered a treatment modality for ADHD.
Methods: The present study is a clinical trial randomized study that was conducted on 84 patients who were divided into two main groups: Group (A): freshly diagnosed cases of ADHD patients who were only receiving sessions of NFB. Group (B): cases of ADHD patients who were receiving both NFB sessions and medications. All participants were treated with methylphenidate capsules with a total dose of 1mg/kg/day in the form of long acting capsules. The total dose was between 20-60 mg. compliance and side effects were recorded. Both groups received 20 sessions of NFB.
Results: there was statistically significant improvement in both groups on neurofeedback therapy with a higher reduction rate in the group receiving combined treatment (neurofeedback and medications) in relation to children receiving neurofeedback therapy alone.
Conclusion: NFB can be considered a treatment modality for improving the symptomatology in children with attention defecit hyperactivity disorder.
Keywords: attention deficit hyperactivity disorder, neurofeedback, theta beta ratio